血纤维蛋白溶酶原 [生化] profibrinolysin ; [生化] plasminogen
人纤维蛋白溶酶原 human plasminogen
人血纤维蛋白溶酶原 human plasminogen
纤维蛋白溶酶原抗体 Anti-PLG
纤维蛋白溶酶原激活素 plasminogen activator
纤维蛋白溶酶原活化剂 plasminogen activator
在两个试验中，在组织纤维蛋白溶酶原激活剂使用前，都先用NIHSS评分。
NIHSS scores were determined before tissue plasminogen activator bolus and at 60 and 120 minutes in both data sets.
这一现象伴随血脑屏障的严重破坏和组织型纤维蛋白溶酶原激活剂治疗后的脑出血率增加。
This was accompanied by severe disruption of the blood-brain barrier and an increased rate of intracerebral hemorrhages after tissue plasminogen activator treatment.
理论分析结果表明，ILLLIT提高了纤维蛋白溶酶原激活素的活性，有利于红细胞聚集指数的下。
The results of theoretical analysis indicate that ILLLIT surely can enhance the activity of plasminogen activator, which is advantageous to decreasing the aggregate degree of erythrocyte.
应用推荐